View of CONSTRUCT THE MODEL OF COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS STANDARD THERAPY FOR THE INITIAL TREATMENT OF VENOUS THROMBOEMBOLISM AND PREVENTION OF RECURRENCE IN VIETNAM

Return to Article Details CONSTRUCT THE MODEL OF COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS STANDARD THERAPY FOR THE INITIAL TREATMENT OF VENOUS THROMBOEMBOLISM AND PREVENTION OF RECURRENCE IN VIETNAM Download Download PDF